Navigation Links
Bay Harbor Podiatry Group Launches New Revolutionary Laser Treatment for Nail Fungus
Date:6/10/2009

LA's Premier South Bay Podiatrists Introduce the Most Effective Safe, Quick & Painless Treatment to Eliminate Stubborn Onychomycosis

TORRANCE, Calif., June 10 /PRNewswire/ -- Bay Harbor Podiatry Group, providing cutting-edge medical treatments and personalized podiatry care for over 25 years, is taking the fight against nail fungus to a new level with the launch of a revolutionary laser treatment that is the most effective at eliminating stubborn toenail fungus (Onychomycosis). Using a laser, the doctors penetrate all toenails without affecting the underlying tissue to eliminate fungus. The treatment is safe, painless and done in a single 30-minute office visit. Results to date show this course of treatment to be nearly 80 percent effective without any side effects.

"I've never been able to offer as powerful, effective and safe a treatment as this new laser technology. And the best part is there are no dangerous side effects, no pharmaceutical prescriptions, and it's achieved during a single office visit," said Dr. Marc G. Mittleman, founder and director of Bay Harbor Podiatry Group. "I've personally seen the embarrassment and shame brought on by this very common disease. Here at last is an effective treatment that allows everyone the chance to show their feet again with pride."

Dr. Mittleman and his physicians treat all toes on both feet with the laser regardless of infection to eliminate the possible spread of the fungus. Patients can expect to see healthy nails within 8 - 10 months.

Onychomycosis affects approximately 35 million people in the U.S. and almost 50% of the population over age 40. It's frequently transmitted in nail salons, gyms and other places where people go without shoes. No single or combined topical treatments have proven to be more than 25 percent effective. While some oral medications tout success rates as high as 65 percent, they require three months of treatment and carry a serious risk of liver damage and require frequent blood testing and monitoring throughout treatment.

With Bay Harbor Podiatry Group's new PinPointe laser treatment, patients can resume physical activities and wear normal shoes or paint their nails immediately following the procedure. For more information, visit www.footcareone.com.

About Bay Harbor Podiatry Group

Bay Harbor Podiatry Group has provided cutting-edge and personalized healthcare to residents of the South Bay area of Los Angeles for over 25 years. Founded and directed by Dr. Marc G. Mittleman, the practice is the first in the area to offer this revolutionary toenail fungus laser treatment. Dr. Mittleman, and his associates, Dr. Michael S. Bloch, and Dr. Roland J. Carroll, III, are certified Diplomates of the American Board of Podiatric Surgery and treat all ailments of the foot and ankle. For more information, visit www.footcareone.com.


'/>"/>
SOURCE Bay Harbor Podiatry Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
2. Cold Spring Harbor scientists devise novel, low-cost method of sifting genomes high-value regions
3. Cold Spring Harbor Protocols features innovative methods for embryology research
4. Cold Spring Harbor Laboratory researchers race against time to save Tasmanian devils
5. Cold Spring Harbor Protocols features high-throughput methods for analyzing gene activity
6. Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation
7. Does 1q31.1-32.1 harbor a tumor suppressor gene related to Chinese SCC patients?
8. Cold Spring Harbor scientists reveal a proteins role in enabling AIDS virus to reproduce
9. Cold Spring Harbor science teams identify 13 new tumor-suppressor genes in liver cancer
10. Announcing a Monumental Sharing of Laser Innovation: The American Society for Laser Medicine and Surgery (ASLMS) Holds 29th Annual Conference in National Harbor, Md., April 1 - 5, 2009
11. Individuals Associated with Vinson Hall Retirement Community, Who Survived Pearl Harbor Attack, to Participate in Navy Memorial Event December 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... of the GlycoMark test throughout the Northeast U.S. , GlycoMark is the ... diabetes. The GlycoMark test provides a clinically proven one- to two-week measure of ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: